Lupin Limited has informed the Exchange regarding a press release dated January 06, 2023, titled "Lupin Receives Approval from U.S. FDA for Fesoterodine Fumarate Extended-ReleaseTablets.".
Press Release Jan 06 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Jan 05 2023
- Press Release Dec 22 2022
- Press Release Dec 21 2022
- Press Release Dec 09 2022
- Press Release Dec 08 2022
Later from Lupin
- Press Release Jan 09 2023
- Press Release Jan 10 2023
- Press Release Jan 16 2023
- Press Release Jan 18 2023
- Press Release Jan 24 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin